Evaluation of the Safety and Tolerability of Inhaled Nitric Oxide to Subjects With Cystic Fibrosis
NCT01958944
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
9
Enrollment
INDUSTRY
Sponsor class
Conditions
Cystic Fibrosis
Interventions
DRUG:
Nitric oxide
Sponsor
Beyond Air Inc.
Collaborators
[object Object]
[object Object]